NCT06651632进行中（未招募）不适用
WATER IV Prostate Cancer: Aquablation Versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 280
- 试验地点
- 62
- 主要终点
- Rate of pad use for urinary incontinence
研究概览
简要总结
This is a multicenter, prospective, randomized clinical trial that aims to assess the safety and efficacy of Aquablation Therapy in men with low-risk to intermediate to high-risk localized prostate cancer who are candidates for, or have opted for, prostatectomy. Participants will be randomized to either Aquablation Therapy or radical prostatectomy and followed up to 10 years.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 45 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Biological male with age ≥ 45 years at the time of consent
- •Biopsy positive Grade Group 1-3 prostate cancer
- •Are candidates for prostatectomy or, in the case of GG1 disease, have already selected a radical therapy as their treatment.
- •Clinical Stage ≤ T2c
- •PSA ≤ 20 ng/ml
- •Prostate volume ≥25 ml
排除标准
- •Any prior or current local or systemic treatment for prostate cancer, including but not limited to surgery, radiation therapy (external or brachytherapy), tissue ablation, hormone therapy or chemotherapy.
- •Patients with previous surgical or minimally invasive treatment of benign prostatic hyperplasia within the prior 3 months of study treatment.
- •Evidence of lymph node, bone metastasis, extracapsular extension or seminal vesicle invasion.
- •Patient is unwilling to accept a blood transfusion if required.
- •Any condition or history of illness or surgery that may pose an additional risk to patients undergoing the Aquablation or radical prostatectomy procedure such as:
- •5a. Medical conditions that preclude the use of anesthesia; 5b. Any condition or history of active rectal inflammatory bowel disease or other factors which might increase the risk of rectal injury (i.e. fistula formation); 5c. Patient is unable to stop anticoagulants or antiplatelet agents prior to study treatment per standard of care; 5d. Any other condition or history of infection, illness or surgery that in the opinion of the investigator might affect the outcome of the study procedure, study conduct, and study results; or pose additional risks to the patient (e.g., other cancer, active urethral stricture disease).
- •6. Patients who are unable to provide informed consent due to cognitive impairment, legal status (such as incarceration), or other factors limiting autonomy or unwilling or unable to follow study instructions including randomization and complete all required study visits through 10 years. This includes individuals with severe cognitive disabilities, those under legal guardianship, or those currently incarcerated.
- •7. Patient currently participating in other studies unless approved by Sponsor in writing.
研究组 & 干预措施
Aquablation Therapy
Experimental
The Aquablation Therapy arm will receive Aquablation with either the AQUABEAM Robotic System or HYDROS Robotic System
干预措施: Aquablation Therapy (Device)
Radical Prostatectomy
Active Comparator
The radical prostatectomy arm will receive the standard of care radical prostatectomy procedure.
干预措施: Radical Prostatectomy (Procedure)
结局指标
主要结局
Rate of pad use for urinary incontinence
时间窗: 6 Months
Rate of erectile dysfunction
时间窗: 6 Months
次要结局
- Rate of pad use for urinary incontinence(3 Months)
- Rate of erectile dysfunction(3 Months)
- Stable or improved Grade Group at 1 year compared to baseline (Aquablation arm only)(1 Year)
研究者
研究点 (62)
Loading locations...
相似试验
已完成
不适用
Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)Benign Prostatic Hyperplasia (BPH)NCT02505919PROCEPT BioRobotics184
已完成
1 期
Prehabilitation for Prostate Cancer SurgeryProstate Cancer Patients Undergoing Radical ProstatectomyNCT02036684University of Guelph-Humber86
招募中
不适用
Clinical Trial of Approaches to Prostate Cancer SurgeryProstate CancerNCT05155501Weill Medical College of Cornell University600
进行中（未招募）
不适用
Prostate Cancer IRE Study (PRIS)Prostate CancerNCT05513443Karolinska Institutet184
进行中（未招募）
不适用
PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic SystemLocalized Prostate CancerNCT06054867PROCEPT BioRobotics22